Literature DB >> 18424977

External carotid artery to middle cerebral artery bypass with the saphenous vein graft.

Erica F Bisson1, Agostino J Visioni, Bruce Tranmer, Michael A Horgan.   

Abstract

Patients with occlusive cerebrovascular disease who have failed maximal medical therapy, which consists of antiplatelet agents as well as maximizing modifiable risk factors such as blood pressure, cholesterol, smoking cessation, and obesity, and whose lesions are not amenable or have not responded to the more common vascular procedures (i.e., carotid endarterectomy or stenting) are considered candidates for an extracranial-intracranial bypass. Additionally, for a patient to be a candidate, he/she must have an adequate graft vessel. Typically, this vessel is the superficial temporal artery. However, oftentimes, the superficial temporal artery is an inadequate vessel or the patient requires a high-flow conduit. It is in these patients that use of the saphenous vein should be considered. In this report, we detail the technical aspects of performing an extracranial-intracranial bypass by using a saphenous vein graft.

Entities:  

Mesh:

Year:  2008        PMID: 18424977     DOI: 10.1227/01.neu.0000317383.53314.3c

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  3 in total

1.  Management of complex intracranial aneurysms with bypass surgery: a technique application and experience in 93 patients.

Authors:  Xiangen Shi; Hai Qian; Tie Fang; Yongli Zhang; Yuming Sun; Fangjun Liu
Journal:  Neurosurg Rev       Date:  2014-08-26       Impact factor: 3.042

Review 2.  Direct Cerebral Revascularization: Extracranial-intracranial Bypass.

Authors:  Sengottuvel Thanapal; Shyam Duvuru; Treepob Sae-Ngow; Yoko Kato; Katsumi Takizawa
Journal:  Asian J Neurosurg       Date:  2018 Jan-Mar

3.  Direct, High-flow Bypass for a Pediatric Giant, Fusiform Aneurysm of the Inferior Division of M2: Case Report and Review of Literature.

Authors:  Vignesh K Alamanda; Luke Tomycz; Dennis Velez; Robert J Singer
Journal:  J Surg Tech Case Rep       Date:  2012-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.